Dr. Kimothy Smith, Chief Science Officer of PositiveID’s ExcitePCR subsidiary. Dr. Smith is a recognized biodefense expert, and in addition to his roles in the private sector and academia, he has held senior level positions at the Department of Homeland Security and national laboratories. He called in to SmallCapVoice.com to go over FireflyDX is and its potential market applications, the significance that the prototype FireflyDX PCR system successfully detected the influenza virus in the lab, and what other viruses or pathogens could be tested at the point of care or point of need.
The FireflyDX™ prototype system is designed to be a portable, fully automated, lab quality, real-time device able to process samples and detect pathogens at the point of care/point of need (POC/PON), faster and less expensively than existing devices.
About PositiveID Corporation
PositiveID Corporation (PSID) is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
On August 24, 2017, PositiveID Corporation and its wholly-owned subsidiary PositiveID Diagnostics, Inc. (collectively, the “Seller”), entered into an Asset Purchase Agreement (“APA”) with ExcitePCR Corporation. Pursuant to the APA, at closing, the Seller will sell and deliver to ExcitePCR all assets used in connection with the operation of the FireflyDX technology. For more information on the APA, please read PositiveID’s Form 8-K filed on August 28, 2017, which can be found here.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 1-9-18 for 30 days of audio interview service. SmallCapVoice.com, Inc. received $875 from the company on 1-30-18 for 30 days of audio interview service.